135 related articles for article (PubMed ID: 21761335)
1. Discovery and validation of breast cancer early detection biomarkers in preclinical samples.
Li CI
Horm Cancer; 2011 Apr; 2(2):125-31. PubMed ID: 21761335
[TBL] [Abstract][Full Text] [Related]
2. Detection of elevated plasma levels of epidermal growth factor receptor before breast cancer diagnosis among hormone therapy users.
Pitteri SJ; Amon LM; Busald Buson T; Zhang Y; Johnson MM; Chin A; Kennedy J; Wong CH; Zhang Q; Wang H; Lampe PD; Prentice RL; McIntosh MW; Hanash SM; Li CI
Cancer Res; 2010 Nov; 70(21):8598-606. PubMed ID: 20959476
[TBL] [Abstract][Full Text] [Related]
3. Candidate early detection protein biomarkers for ER+/PR+ invasive ductal breast carcinoma identified using pre-clinical plasma from the WHI observational study.
Buas MF; Rho JH; Chai X; Zhang Y; Lampe PD; Li CI
Breast Cancer Res Treat; 2015 Sep; 153(2):445-54. PubMed ID: 26319120
[TBL] [Abstract][Full Text] [Related]
4. Discovery and preliminary confirmation of novel early detection biomarkers for triple-negative breast cancer using preclinical plasma samples from the Women's Health Initiative observational study.
Li CI; Mirus JE; Zhang Y; Ramirez AB; Ladd JJ; Prentice RL; McIntosh MW; Hanash SM; Lampe PD
Breast Cancer Res Treat; 2012 Sep; 135(2):611-8. PubMed ID: 22903690
[TBL] [Abstract][Full Text] [Related]
5. Evaluating Serum Markers for Hormone Receptor-Negative Breast Cancer.
Schummer M; Thorpe J; Giraldez MD; Bergan L; Tewari M; Urban N
PLoS One; 2015; 10(11):e0142911. PubMed ID: 26565788
[TBL] [Abstract][Full Text] [Related]
6. Concordant release of glycolysis proteins into the plasma preceding a diagnosis of ER+ breast cancer.
Amon LM; Pitteri SJ; Li CI; McIntosh M; Ladd JJ; Disis M; Porter P; Wong CH; Zhang Q; Lampe P; Prentice RL; Hanash SM
Cancer Res; 2012 Apr; 72(8):1935-42. PubMed ID: 22367215
[TBL] [Abstract][Full Text] [Related]
7. Discovery and preclinical validation of salivary transcriptomic and proteomic biomarkers for the non-invasive detection of breast cancer.
Zhang L; Xiao H; Karlan S; Zhou H; Gross J; Elashoff D; Akin D; Yan X; Chia D; Karlan B; Wong DT
PLoS One; 2010 Dec; 5(12):e15573. PubMed ID: 21217834
[TBL] [Abstract][Full Text] [Related]
8. An integrated cell line-based discovery strategy identified follistatin and kallikrein 6 as serum biomarker candidates of breast carcinoma.
Mangé A; Dimitrakopoulos L; Soosaipillai A; Coopman P; Diamandis EP; Solassol J
J Proteomics; 2016 Jun; 142():114-21. PubMed ID: 27168011
[TBL] [Abstract][Full Text] [Related]
9. Identification of vitronectin as a novel serum marker for early breast cancer detection using a new proteomic approach.
Kadowaki M; Sangai T; Nagashima T; Sakakibara M; Yoshitomi H; Takano S; Sogawa K; Umemura H; Fushimi K; Nakatani Y; Nomura F; Miyazaki M
J Cancer Res Clin Oncol; 2011 Jul; 137(7):1105-15. PubMed ID: 21253761
[TBL] [Abstract][Full Text] [Related]
10. Testing breast cancer serum biomarkers for early detection and prognosis in pre-diagnosis samples.
Kazarian A; Blyuss O; Metodieva G; Gentry-Maharaj A; Ryan A; Kiseleva EM; Prytomanova OM; Jacobs IJ; Widschwendter M; Menon U; Timms JF
Br J Cancer; 2017 Feb; 116(4):501-508. PubMed ID: 28081538
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and predictive value of EGFR and EGFR-ligands in blood of breast cancer patients: a systematic review.
Kjaer IM; Bechmann T; Brandslund I; Madsen JS
Clin Chem Lab Med; 2018 Apr; 56(5):688-701. PubMed ID: 29194036
[TBL] [Abstract][Full Text] [Related]
12. Serum epidermal growth factor receptor and HER2 expression in primary and metastatic breast cancer patients.
Asgeirsson KS; Agrawal A; Allen C; Hitch A; Ellis IO; Chapman C; Cheung KL; Robertson JF
Breast Cancer Res; 2007; 9(6):R75. PubMed ID: 17976236
[TBL] [Abstract][Full Text] [Related]
13. Integration of Serum Protein Biomarker and Tumor Associated Autoantibody Expression Data Increases the Ability of a Blood-Based Proteomic Assay to Identify Breast Cancer.
Henderson MC; Hollingsworth AB; Gordon K; Silver M; Mulpuri R; Letsios E; Reese DE
PLoS One; 2016; 11(8):e0157692. PubMed ID: 27508384
[TBL] [Abstract][Full Text] [Related]
14. Comparative profiling of plasma proteome from breast cancer patients reveals thrombospondin-1 and BRWD3 as serological biomarkers.
Suh EJ; Kabir MH; Kang UB; Lee JW; Yu J; Noh DY; Lee C
Exp Mol Med; 2012 Jan; 44(1):36-44. PubMed ID: 22024541
[TBL] [Abstract][Full Text] [Related]
15. Identification of Developmental Endothelial Locus-1 on Circulating Extracellular Vesicles as a Novel Biomarker for Early Breast Cancer Detection.
Moon PG; Lee JE; Cho YE; Lee SJ; Jung JH; Chae YS; Bae HI; Kim YB; Kim IS; Park HY; Baek MC
Clin Cancer Res; 2016 Apr; 22(7):1757-66. PubMed ID: 26603257
[TBL] [Abstract][Full Text] [Related]
16. A Noninvasive Blood-based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Women Under the Age of 50 Years.
Lourenco AP; Benson KL; Henderson MC; Silver M; Letsios E; Tran Q; Gordon KJ; Borman S; Corn C; Mulpuri R; Smith W; Alpers J; Costantini C; Rohatgi N; Yang R; Haythem A; Biren S; Morris M; Kass F; Reese DE
Clin Breast Cancer; 2017 Nov; 17(7):516-525.e6. PubMed ID: 28624156
[TBL] [Abstract][Full Text] [Related]
17. Dysregulated EGFR pathway in serum in early-stage breast cancer patients: A case control study.
Kjær IM; Olsen DA; Brandslund I; Bechmann T; Jakobsen EH; Bogh SB; Madsen JS
Sci Rep; 2020 Apr; 10(1):6714. PubMed ID: 32317675
[TBL] [Abstract][Full Text] [Related]
18. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
Zhang L; Xu Y; Jin X; Wang Z; Wu Y; Zhao D; Chen G; Li D; Wang X; Cao H; Xie Y; Liang Z
Breast Cancer Res Treat; 2015 Nov; 154(2):423-34. PubMed ID: 26476723
[TBL] [Abstract][Full Text] [Related]
19. Plasma biomarker profiles differ depending on breast cancer subtype but RANTES is consistently increased.
Gonzalez RM; Daly DS; Tan R; Marks JR; Zangar RC
Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1543-51. PubMed ID: 21586622
[TBL] [Abstract][Full Text] [Related]
20. Construction and analysis of the NCI-EDRN breast cancer reference set for circulating markers of disease.
Marks JR; Anderson KS; Engstrom P; Godwin AK; Esserman LJ; Longton G; Iversen ES; Mathew A; Patriotis C; Pepe MS
Cancer Epidemiol Biomarkers Prev; 2015 Feb; 24(2):435-41. PubMed ID: 25471344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
